Loading company…
Riskpilot
← Back to search
Sign in
Get full access
V.GULDMANN NUF
NUF
Active
Org 922275513
Bønsdalvegen 32, 2073 Bøn
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2019
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 21,7M
+32% vs 2024
EBITDA margin
6.8%
+22% vs 2024
Equity ratio
74.5%
Financial strength
Net profit 2025
NOK 1,2M
+24% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2021
1M
+100%
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 21,7M
+32%
EBITDA
NOK 1,5M
+22%
Net profit
NOK 1,2M
+24%
Total assets
NOK 7,6M
-2%
Equity
NOK 5,6M
-8%
Employees
2
—
Company information
Legal name
V.GULDMANN NUF
Org number
922275513
Legal form
Norskregistrert Utenlandsk Foretak
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2. mars 2019
Share capital
—
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Company purpose
Salg av pasientløftere og utstyr til helsevesenet.
Contact
Address
Bønsdalvegen 32, 2073 Bøn
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Eidsvoll
All Norway companies
Revenue
NOK millions
0M
6M
13M
19M
25M
6M
2021
10M
2022
19M
2023
16M
2024
22M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
1M
2023
1M
2024
1M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
5 963
10 002
19 017
16 473
21 677
Staff expenses
−1 446
−1 354
−1 782
−1 693
−1 531
EBITDA
407
682
1 296
1 199
1 468
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
407
682
1 296
1 199
1 468
Net financials
−0
−0
1
5
24
Profit before tax
406
682
1 297
1 204
1 492
Tax
89
150
285
265
328
Net profit
317
532
1 012
939
1 164
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 094
6 488
8 878
7 694
7 558
Equity
2 625
4 643
6 563
6 094
5 629
Long-term debt
0
0
0
0
0
Short-term debt
469
1 845
2 315
1 600
1 929
Total debt
469
1 845
2 315
1 600
1 929
Financial ratios
5-year trend
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
2021
2025
Equity ratio
74.5%
This company
38.2%
Market median
+95% vs market
2021
2025
Return on equity
20.7%
This company
18.4%
Market median
+13% vs market
2021
2025
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
2021
2025
Asset turnover
2.87×
This company
1.12×
Market median
+156% vs market
2021
2025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-10-01 – 2021-09-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
MG
Michael Gundelund Nielsen
Chief Executive Officer
Chief Executive Officer
2025
SW
Stine Wenstad Myrvang
Chief Executive Officer
Chief Executive Officer
2019
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of V.GULDMANN NUF also hold positions in
0
other companies.
Person
Role here
Other companies
Michael Gundelund Nielsen
Chief Executive Officer
0 companies
Stine Wenstad Myrvang
Chief Executive Officer
0 companies